Hunan Er Kang Pharmaceutical Cash Flow Conversion Efficiency

Latest as of June 2023: 0.034x

Hunan Er Kang Pharmaceutical cash flow conversion efficiency. Based on the latest financial reports, Hunan Er Kang Pharmaceutical (300267) has a cash flow conversion efficiency ratio of 0.034x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥174.55 Million ≈ $25.54 Million USD) by net assets (CN¥5.09 Billion ≈ $745.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hunan Er Kang Pharmaceutical (2008–2024)

Cash flow conversion efficiency of Hunan Er Kang Pharmaceutical from 2008 to 2024. This chart illustrates how Hunan Er Kang Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300267 stock price and chart for real-time trading data and today's change.

Hunan Er Kang Pharmaceutical Cash Flow Conversion Ratio Explained

Hunan Er Kang Pharmaceutical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hunan Er Kang Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Er Kang Pharmaceutical ranked by their cash flow conversion efficiency. Also see 300267 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Jiangsu Gian Technology Co Ltd SHE:300709	0.215x
HOB Biotech Group Corp Ltd SHG:688656	0.018x
Beijing Hotgen Biotech Co Ltd SHG:688068	0.001x
Synsam AB ST:SYNSAM	0.144x
Shandong Intco Recycling Resources Co Ltd SHG:688087	0.063x
Ficont Industry (Beijing) Co. Ltd. SHG:605305	0.028x
Gr. Sarantis S.A. AT:SAR	0.008x
UNITIL Corporation NYSE:UTL	0.026x

Annual Cash Flow Conversion Efficiency for Hunan Er Kang Pharmaceutical (2008–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Er Kang Pharmaceutical from 2008 to 2024. Review 300267 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.40 Billion ≈ $644.18 Million	CN¥166.69 Million ≈ $24.39 Million	0.038x	+22.71%
2023-12-31	CN¥4.81 Billion ≈ $703.86 Million	CN¥148.42 Million ≈ $21.72 Million	0.031x	-44.54%
2022-12-31	CN¥5.05 Billion ≈ $739.13 Million	CN¥281.02 Million ≈ $41.12 Million	0.056x	+192.56%
2021-12-31	CN¥4.87 Billion ≈ $713.18 Million	CN¥92.68 Million ≈ $13.56 Million	0.019x	-38.29%
2020-12-31	CN¥5.79 Billion ≈ $847.78 Million	CN¥178.53 Million ≈ $26.12 Million	0.031x	-59.96%
2019-12-31	CN¥5.79 Billion ≈ $847.71 Million	CN¥445.82 Million ≈ $65.24 Million	0.077x	+250.28%
2018-12-31	CN¥5.64 Billion ≈ $825.21 Million	CN¥123.89 Million ≈ $18.13 Million	0.022x	-82.75%
2017-12-31	CN¥5.41 Billion ≈ $791.90 Million	CN¥689.11 Million ≈ $100.84 Million	0.127x	+37.27%
2016-12-31	CN¥5.24 Billion ≈ $767.41 Million	CN¥486.50 Million ≈ $71.19 Million	0.093x	-23.90%
2015-12-31	CN¥4.26 Billion ≈ $622.97 Million	CN¥518.96 Million ≈ $75.94 Million	0.122x	+16.62%
2014-12-31	CN¥1.68 Billion ≈ $245.53 Million	CN¥175.38 Million ≈ $25.66 Million	0.105x	-19.97%
2013-12-31	CN¥1.33 Billion ≈ $195.21 Million	CN¥174.22 Million ≈ $25.49 Million	0.131x	+80.97%
2012-12-31	CN¥1.16 Billion ≈ $170.37 Million	CN¥84.02 Million ≈ $12.30 Million	0.072x	+1.24%
2011-12-31	CN¥1.06 Billion ≈ $155.44 Million	CN¥75.72 Million ≈ $11.08 Million	0.071x	-70.36%
2010-12-31	CN¥176.62 Million ≈ $25.85 Million	CN¥42.47 Million ≈ $6.21 Million	0.240x	+159.86%
2009-12-31	CN¥110.01 Million ≈ $16.10 Million	CN¥10.18 Million ≈ $1.49 Million	0.093x	+2663.24%
2008-12-31	CN¥63.01 Million ≈ $9.22 Million	CN¥211.00K ≈ $30.88K	0.003x	--

About Hunan Er Kang Pharmaceutical

SHE:300267 China Drug Manufacturers - Specialty & Generic

Market Cap

$878.31 Million

CN¥6.00 Billion CNY

Market Cap Rank

#9106 Global

#2171 in China

Share Price

CN¥2.91

Change (1 day)

-0.68%

52-Week Range

CN¥2.77 - CN¥4.84

All Time High

CN¥17.60